10 News & Press Releases found
Atomwise Inc. News
-
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today the appointment of David Thomson, Ph.D. as Chief Scientific Officer. Additional management team appointments include Jonathan Barr as Chief ...
-
Atomwise Invited to Present at the 2022 J.P. Morgan Healthcare Conference
Atomwise, a technology-enabled pharmaceutical company leveraging the power of artificial intelligence (AI) to revolutionize small molecule drug discovery, today announced that it has been invited to present next week at the 40th Annual J.P. ...
-
Atomwise Adds Pharma Luminaries to Board of Directors and Scientific Advisory Board
Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its ...
-
Atomwise Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021
Atomwise, a leader in using artificial intelligence (AI) for small -molecule drug discovery, today announced it has been named to Fast Company`s prestigious annual list of the World`s Most Innovative Companies for 2021. Atomwise was recognized for ...
-
Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded by Leading Biopharma VCs and the Israeli Innovation Authority
Atomwise, the leader in using artificial intelligence (AI) for small-molecule drug discovery, announced today a partnership with FutuRx, a recognized Israeli-based biotechnology incubator focused on innovative, early-stage therapeutic ...
-
Atomwise Receives a $2.3M Grant to Develop New Therapies for Drug Resistant Malaria and Tuberculosis
The $2.3M in grant funding from the Bill & Melinda Gates Foundation will support the development of multiple global health programs to advance novel antimalarial and anti-tuberculosis small molecule therapies in collaboration with the ...
-
GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today a partnership with GC Pharma (KRX: 006280), a South Korean biopharmaceutical company formerly known as Green Cross Corporation, ...
-
Atomwise Named to the 2020 CB Insights Digital Health 150 - List of Most Innovative Digital Health Startups
CB Insights today named Atomwise to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. The 2020 Digital Health 150 cohort highlights ...
-
Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks
Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today it has fifteen research collaborations underway with leading global universities to explore broad-spectrum therapies for COVID-19 and other ...
-
Hansoh Expands AI Partnership with Atomwise after Early Success for Key Target in Therapy-Evading Cancers
Hansoh Pharma (3692:HK), a leading biopharmaceutical company in China, and Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced the expansion of their strategic partnership for AI-accelerated drug ...